Clinical Trials on Primary Central Nervous System Non-Hodgkin Lymphoma
Total 99189 results
-
Estrella Biopharma, Inc.Eureka Therapeutics Inc.Not yet recruitingLymphoma | Lymphoma, Non-Hodgkin | Non-Hodgkin's Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | High-grade B-cell Lymphoma | CNS Lymphoma | Lymphomas Non-Hodgkin's B-Cell | Relapsed Non-Hodgkin Lymphoma | Lymphoma, Non-Hodgkins | Large B-Cell Lymphoma and other conditions
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineRecruitingHodgkins Lymphoma | Non Hodgkins LymphomaUnited States
-
Spectrum Pharmaceuticals, IncCompletedNon-Hodgkins Lymphoma | Tumors | Hodgkins DiseaseUnited States, Canada
-
Case Comprehensive Cancer CenterTerminatedPrimary Central Nervous System Non-Hodgkin LymphomaUnited States
-
Stanford UniversityNational Institutes of Health (NIH); AmgenCompletedLymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous Lymphoma | Lymphomas: Non-Hodgkin Diffuse Large B-Cell | Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell | Lymphomas: Non-Hodgkin Mantle Cell | Lymphomas: Non-Hodgkin Marginal... and other conditionsUnited States
-
Baylor College of MedicineThe Methodist Hospital Research InstituteTerminatedNon-Hodgkin Lymphoma | Hodgkins LymphomaUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...TerminatedHodgkin Disease | Non-Hodgkins LymphomaUnited States
-
University Hospital FreiburgUniversity Hospital TuebingenUnknown
-
Oncology Specialists, S.C.University of Illinois at ChicagoTerminatedNon-Hodgkin LymphomasUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedIndolent B-Cell Non-Hodgkin's LymphomasChina
-
University of GiessenCompletedMarginal Zone Lymphomas | Non-Hodgkin Lymphomas | Follicular Lymphomas | Immunocytomas | Lymphocytic LymphomasGermany
-
Lakshmi Nayak, MDKazia Therapeutics LimitedRecruitingPrimary Central Nervous System Lymphoma | Non-Hodgkin Lymphoma of Extranodal SiteUnited States
-
University of PennsylvaniaCompletedNon-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell LymphomasUnited States
-
SCRI Development Innovations, LLCBiogenCompleted
-
SCRI Development Innovations, LLCGenentech, Inc.; AmgenCompletedNon-Hodgkins LymphomaUnited States
-
University of NebraskaSchering-PloughCompletedNon-Hodgkins LymphomaUnited States
-
Institut fuer anwendungsorientierte Forschung und...CompletedPrimary Non-Hodgkin-Lymphoma | Refractory Non-Hodgkin-Lymphoma | CD20+ Aggressive Non-Hodgkin's LymphomaGermany
-
Columbia UniversityCelgeneTerminatedLymphoma | Hodgkin Lymphoma | Lymphoid Malignancies | Non-hodgkin LymphomaUnited States
-
Weill Medical College of Cornell UniversityCompletedHodgkins Disease | Lymphoma, Non-HodgkinsUnited States
-
Genentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaUnited States, France, Canada, Netherlands
-
Columbia UniversityCompletedNon-Hodgkin's Lymphoma | Hodgkins DiseaseUnited States
-
University Health Network, TorontoCompletedHodgkin's Lymphoma | Non Hodgkin's LymphomaCanada
-
The Lymphoma Academic Research OrganisationCompletedNon-Hodgkin's LymphomasFrance
-
National Cancer Institute (NCI)CompletedLymphoma, B-Cell | Leukemia, B-cell | Lymphoma, Hodgkins | Lymphoma, Non-hodgkinsUnited States
-
St. Jude Children's Research HospitalParexel; Jazz PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Non Hodgkins LymphomaUnited States
-
John ReneauActive, not recruitingRecurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma | Primary Cutaneous Anaplastic Large Cell Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin... and other conditionsUnited States
-
Baylor College of MedicineNational Cancer Institute (NCI); The Methodist Hospital Research Institute; Center...Active, not recruitingHodgkin Disease | Hodgkin Lymphoma | Non-Hodgkin LymphomaUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Pfizer; Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkins LymphomaUnited States
-
Maisonneuve-Rosemont HospitalBayerUnknownNon-Hodgkins LymphomaCanada
-
Royal Marsden NHS Foundation TrustCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | High Grade B-Cell Non-Hodgkin's Lymphoma | Intermediate Grade B-Cell Non-Hodgkin's LymphomaUnited States
-
Precision BioSciences, Inc.CompletedLymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B-cell Non Hodgkin Lymphoma | Leukemia, Lymphocytic, Chronic | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Marker Therapeutics, Inc.RecruitingNon Hodgkin Lymphoma | Non-Hodgkin Lymphoma, Adult | Non-Hodgkin Lymphoma, Refractory | Non-Hodgkin Lymphoma, RelapsedUnited States
-
Genzyme, a Sanofi CompanyTerminatedNon-Hodgkins LymphomaUnited States
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Hodgkin Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Eureka Therapeutics Inc.Duke University; Duke Clinical Research InstituteTerminatedLymphomas Non-Hodgkin's B-CellUnited States
-
Biovest InternationalUnknown
-
National Cancer Institute (NCI)TerminatedLeukemia | Multiple Myeloma | MDS | Non-Hodgkins Lymphoma | Hodgkins LymphomaUnited States
-
Caribou Biosciences, Inc.RecruitingLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | B Cell Non-Hodgkin's LymphomaUnited States, Australia, Israel
-
John ReneauRecruitingRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Adult T-Cell Leukemia/LymphomaUnited States
-
Gilead SciencesTerminated
-
Chongqing Precision Biotech Co., LtdRecruitingNon Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaChina
-
Burzynski Research InstituteTerminatedNon-hodgkins LymphomaUnited States
-
Burzynski Research InstituteTerminatedNon-hodgkins LymphomaUnited States
-
Cortice Biosciences, Inc.CompletedNeoplasms | Hodgkin Disease | Non-Hodgkin LymphomaUnited States
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States
-
Genzyme, a Sanofi CompanyCompletedHodgkin Disease | Non-Hodgkin LymphomaUnited States
-
Virginia Commonwealth UniversityWithdrawnMalignant Childhood Neoplasm | Childhood Hodgkin Lymphoma | Childhood Brain Tumor | Childhood Non-Hodgkin Lymphoma